Evidence map›Paper›PMID 28989562›Full record

ArticleStatistics and its interface2015

A Bayesian approach to identify genes and gene-level SNP aggregates in a genetic analysis of cancer data.

Francesco C Stingo, Michael D Swartz, Marina Vannucci

Abstract read
In one paragraph

Article in Statistics and its interface, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francesco C StingoDepartment of Biostatistics, MD Anderson Cancer Center, 1400 Pressler St. Houston, TX 77030, USA.
Michael D SwartzDepartment of Biostatistics, UT School of Public Health, 1200 Pressler St. Houston, TX 77030, USA.
Marina VannucciDepartment of Statistics, MS 138, Rice University, 6100 Main St. Houston, TX 77251-1892 USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Research ServicesP01HL082798 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU · 2006 to 2015
$22.0M
Bayesian Hierarchical Risk Models: Nutrition, Genes, & Environment InteractionsK07CA123109 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SWARTZ, MICHAEL D · 2007 to 2011
$659k
A Novel Bayesian Model Averaging Approach for Genome Wide Association StudiesR03CA141998 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SWARTZ, MICHAEL D · 2009 to 2010
$154k
NCI NIH HHS K07 CA123109NCI NIH HHS P30 CA016672NCI NIH HHS R03 CA141998NHLBI NIH HHS P01 HL082798
6 · The paper itself

Abstract

Complex diseases, such as cancer, arise from complex etiologies consisting of multiple single-nucleotide polymorphisms (SNPs), each contributing a small amount to the overall risk of disease. Thus, many researchers have gone beyond single-SNPs analysis methods, focusing instead on groups of SNPs, for example by analysing haplotypes. More recently, pathway-based methods have been proposed that use prior biological knowledge on gene function to achieve a more powerful analysis of genome-wide association studies (GWAS) data. In this paper we propose a novel Bayesian modeling framework to identify molecular biomarkers for disease prediction. Our method combines pathway-based approaches with multiple SNP analyses of a specified region of interest. The model's development is motivated by SNP data from a lung cancer study. In our approach we define gene-level scores based on SNP allele frequencies and use a linear modeling setting to study the scores association to the observed phenotype. The basic idea behind the definition of gene-level scores is to weigh the SNPs within the gene according to their rarity, based on genotype frequencies expected under the Hardy-Weinberg equilibrium law. This results in scores giving more importance to the unusually low frequencies, i.e. to SNPs that might indicate peculiar genetic differences between subjects belonging to different groups. An additional feature of our approach is that we incorporate information on SNP-to-SNP associations into the model. In particular, we use network priors that model the linkage disequilibrium between SNPs. For posterior inference, we design a stochastic search method that identifies significant biomarkers (genes and SNPs) for disease prediction. We assess performances on simulated data and compare results to existing approaches. We then show the ability of the proposed methodology to detect relevant genes and associated SNPs in a lung cancer dataset.

Indexed as

Bayesian variable selectionHardy-Weinberg equilibrium lawLinear modelsLinkage disequilibriumMarkov random fieldSNP data

Identifiers

PMID28989562
PMCPMC5630184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.